neoadjuvant chemotherapy

(redirected from Neoadjuvant)
Also found in: Dictionary, Medical, Wikipedia.

neoadjuvant chemotherapy

[‚nē·ō¦aj·ə·vənt ‚kē·mō′ther·ə·pē]
(medicine)
A type of chemotherapy that is used to shrink a tumor prior to surgery or radiation.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Patient Characteristics Concomitant Neoadjuvant Neoadjuvant p Chemoradiation Chemotherapy Chemotherapy Value Using Followed by Followed by Conventional Hypo- Concomitant Fractionation Fractionated Chemoradiation Radiotherapy Number of 48 53 55 patients Median age 50 years 54 years 53 years 0.99 Stage IB2 3 2 2 0.72 IIA2 4 3 6 IIB 12 15 17 III 26 29 22 IVA 3 4 8 Table 2.
By working closely with the FDA and participating in the Real-Time Oncology Review pilot program, we are able to make Kadcyla available for people with residual invasive disease after neoadjuvant therapy much sooner than anticipated," said Sandra Horning, M.D., chief medical officer and head of Global Product Development.
Diffusion-weighted MRI has been shown to help detection, characterization, staging, and evaluation of neoadjuvant treatment response for rectal cancer (17).
Detection of metastases in the regional and distant lymph nodes plays a key role in the planning of neoadjuvant or systemic treatment.
In patients receiving neoadjuvant chemotherapy, the tumor size is monitored radiologically prior to surgical treatment to determine the efficacy of the treatment, whether the patient is eligible for surgery, and the appropriate surgical technique to be applied (3).
Roche's application for the drug is based on the data from its phase 3 KATHERINE trial held in patients with HER2-positive early breast cancer who have residual disease present after neoadjuvant treatment.
Neoadjuvant concurrent chemoradiotherapy was planned, consisting of oral capecitabine 825mg/m2 BID five days a week along with 50.4 Gy Radiotherapy with linac machine.
Neoadjuvant chemotherapy is the administration ofintravenous therapeuticagents to reduce a tumor in advance of another treatment such as surgery.
The aim of the study was to assess the accuracy of the computerized tomographic (CT) scan as the only widely used staging modality for colonic cancer in the preoperative detection of regional lymph node metastases and EMVI because these factors may potentially help in the selection of patients suitable for neoadjuvant chemotherapy
WEDNESDAY, May 2, 2018 (HealthDay News) -- For patients with locally advanced esophageal cancer, the status of lymph nodes following preoperative neoadjuvant chemotherapy or chemoradiation therapy determines survival, according to a study presented at the annual meeting of the American Association for Thoracic Surgery, held from April 28 to May 1 in San Diego.
Background: Most studies on enhanced recovery after surgery (ERAS) for gastric cancer exclude patients who received neoadjuvant chemotherapy.